CD4 + CD25high Regulatory T Cell Numbers and FOXP3 mRNA Expression in Patients with Advanced Esophageal Cancer Before and After Chemotherapy

被引：0

作者：

Tengyun Xu

Qiaohong Duan

Gang Wang

Bing Hu

机构：

[1] Anhui Medical University Affiliated Anhui Provincial Hospital,Department of Oncology

来源：

Cell Biochemistry and Biophysics | 2011年 / 61卷

关键词：

Advanced esophageal cancer; CD4 + CD25; regulatory T cells; FOXP3;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We evaluated the changes in CD4 + CD25high regulatory T (Treg) cells and FOXP3 mRNA expression in patients with advanced esophageal cancer as well as its clinical significance. For this purpose, the frequencies of peripheral blood Treg cells in 68 patients with advanced esophageal cancer and 40 healthy controls were determined by flow cytometry, and FOXP3 mRNA expression in Treg cells of 40 patients was determined by RT–PCR. The data show that Treg cell numbers were significantly higher (P < 0.01) in esophageal cancer patients (1.82 ± 0.54% of CD4 + T cells) as compared with healthy controls (1.52 ± 0.70% of CD4+ T cells). Treg cell numbers in the patients were significantly higher (P < 0.05) before chemotherapy (1.82 ± 0.54% of CD4 + T cells) than after chemotherapy (1.66 ± 0.58% of CD4 + T cells). Expression of the FOXP3 mRNA in the patients was significantly lower (P < 0.05) after chemotherapy (0.266 ± 0.028% of CD4 + T cells) than before chemotherapy (0.318 ± 0.027% of CD4 + T cells). It was, therefore, concluded that Treg cell numbers as well as FOXP3 mRNA expression in advanced esophageal cancer patients were significantly decreased after chemotherapy. Notably, FOXP3 gene may thus be involved in regulating the numbers and function of Treg cells in advanced esophageal cancer patients receiving chemotherapy.

引用

页码：389 / 392

页数：3

共 47 条

[1]

Paust S(2005)Regulatory T cells and autoimmune disease Immunological Review 204 195-207

[2]

Cantor H(2003)The role of regulatory T cells in controlling immunologic self-tolerance International Review of Cytology 225 1-32

[3]

Takahashi T(2004)Immunoregulatory T cells in tumor immunity Current Opinion in Immunology 16 157-162

[4]

Sakaguchi S(2003)Increase of regulatory T cells in the peripheral blood of cancer patients Clinical Cancer Research 9 606-612

[5]

Terabe M(2003)Control of regulatory T cell development by the transcription factor Foxp3 Science 299 1057-1061

[6]

Berzofsky JA(2007)Emerging challenges in regulatory T cell function and biology Science 317 627-629

[7]

Wolf AM(2007)Foxp3 is required throughout the life of a regulatory T cell Science STKE 393 pe36-1099

[8]

Wolf D(2003)CD4 + CD25 + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 1089-691

[9]

Steurer M(2006)Intra-tumoral regulatory T cells: a potential new target in cancer immunotherapy Biochemical and Biophysical Research Communications 343 684-1273

[10]

Gastl G(2005)CD4 + CD25 + regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer Oncological Report 14 1269-4408

← 1 2 3 4 5 →